輝煌科技(002296.SZ):中標5.5億元鄭州軌道交通項目
格隆匯 11 月 23日丨輝煌科技(002296.SZ)公佈,近日,公司收到鄭州地鐵集團有限公司發來的《中標通知書》,確定公司為“鄭州市軌道交通6號線一期、10號線一期、鄭州機場至許昌市域鐵路工程(鄭州段)綜合監控系統集成項目”的中標單位,中標金額約5.5億元人民幣。
該項目中標金額約5.5億元,佔公司2019年度經審計的營業總收入的108.97%。若該項目能夠順利簽訂合同並實施,將提升公司在河南地區城市軌道交通領域的市場影響力和競爭力,也將對公司未來的經營業績產生積極影響。該項目的履行不影響公司經營的獨立性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.